Publication | Open Access

A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)

Cervical CancerMedicineMetronomic TherapyGynecologyPathologyRecurrent CarcinomaCancer TreatmentOncologyRadiation OncologyGynecology OncologyMolecular OncologyNrg Oncology Study